BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14871885)

  • 21. BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner.
    Zhang F; Dey D; Bränström R; Forsberg L; Lu M; Zhang Q; Sjöholm A
    Am J Physiol Cell Physiol; 2009 Feb; 296(2):C346-54. PubMed ID: 19052259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMP-activated protein kinase regulates glucagon secretion from mouse pancreatic alpha cells.
    Leclerc I; Sun G; Morris C; Fernandez-Millan E; Nyirenda M; Rutter GA
    Diabetologia; 2011 Jan; 54(1):125-34. PubMed ID: 20938634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Pancreatic β Cell Mass by Cross-Interaction between CCAAT Enhancer Binding Protein β Induced by Endoplasmic Reticulum Stress and AMP-Activated Protein Kinase Activity.
    Matsuda T; Takahashi H; Mieda Y; Shimizu S; Kawamoto T; Matsuura Y; Takai T; Suzuki E; Kanno A; Koyanagi-Kimura M; Asahara S; Bartolome A; Yokoi N; Inoue H; Ogawa W; Seino S; Kido Y
    PLoS One; 2015; 10(6):e0130757. PubMed ID: 26091000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase.
    Kefas BA; Cai Y; Ling Z; Heimberg H; Hue L; Pipeleers D; Van de Casteele M
    J Mol Endocrinol; 2003 Apr; 30(2):151-61. PubMed ID: 12683939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serine-385 phosphorylation of inwardly rectifying K+ channel subunit (Kir6.2) by AMP-dependent protein kinase plays a key role in rosiglitazone-induced closure of the K(ATP) channel and insulin secretion in rats.
    Chang TJ; Chen WP; Yang C; Lu PH; Liang YC; Su MJ; Lee SC; Chuang LM
    Diabetologia; 2009 Jun; 52(6):1112-21. PubMed ID: 19357830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
    Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
    Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMP-activated protein kinase: a new beta-cell glucose sensor?: Regulation by amino acids and calcium ions.
    Leclerc I; Rutter GA
    Diabetes; 2004 Dec; 53 Suppl 3():S67-74. PubMed ID: 15561925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.
    Sugden MC; Bulmer K; Augustine D; Holness MJ
    Diabetes; 2001 Dec; 50(12):2729-36. PubMed ID: 11723055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.
    Xie Z; Dong Y; Scholz R; Neumann D; Zou MH
    Circulation; 2008 Feb; 117(7):952-62. PubMed ID: 18250273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AMP-activated protein kinase in metabolic control and insulin signaling.
    Towler MC; Hardie DG
    Circ Res; 2007 Feb; 100(3):328-41. PubMed ID: 17307971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase.
    Leclerc I; Lenzner C; Gourdon L; Vaulont S; Kahn A; Viollet B
    Diabetes; 2001 Jul; 50(7):1515-21. PubMed ID: 11423471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.
    Musi N; Hirshman MF; Nygren J; Svanfeldt M; Bavenholm P; Rooyackers O; Zhou G; Williamson JM; Ljunqvist O; Efendic S; Moller DE; Thorell A; Goodyear LJ
    Diabetes; 2002 Jul; 51(7):2074-81. PubMed ID: 12086935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets.
    Liu L; Liu J; Gao Y; Yu X; Xu G; Huang Y
    Br J Pharmacol; 2014 Jul; 171(13):3246-54. PubMed ID: 24588674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations.
    Lamontagne J; Pepin E; Peyot ML; Joly E; Ruderman NB; Poitout V; Madiraju SR; Nolan CJ; Prentki M
    Endocrinology; 2009 Aug; 150(8):3465-74. PubMed ID: 19406947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AMP-activated protein kinase and muscle glucose uptake.
    Musi N; Goodyear LJ
    Acta Physiol Scand; 2003 Aug; 178(4):337-45. PubMed ID: 12864738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity.
    Mountjoy PD; Bailey SJ; Rutter GA
    Diabetologia; 2007 Jan; 50(1):168-77. PubMed ID: 17093945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate.
    Sun Y; Ren M; Gao GQ; Gong B; Xin W; Guo H; Zhang XJ; Gao L; Zhao JJ
    Acta Pharmacol Sin; 2008 Apr; 29(4):443-50. PubMed ID: 18358090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
    Gaidhu MP; Fediuc S; Ceddia RB
    J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigallocatechin-3-gallate (EGCG) activates AMPK through the inhibition of glutamate dehydrogenase in muscle and pancreatic ß-cells: A potential beneficial effect in the pre-diabetic state?
    Pournourmohammadi S; Grimaldi M; Stridh MH; Lavallard V; Waagepetersen HS; Wollheim CB; Maechler P
    Int J Biochem Cell Biol; 2017 Jul; 88():220-225. PubMed ID: 28137482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.